Skip to content

Polaryx Therapeutics, Inc. PLYX Deferred Tax Assets - Tax Credit Carryforwards

Deferred Tax Assets - Tax Credit Carryforwards at other companies

General Dynamics logo
General DynamicsGD
$384M+108%
PPG Industries logo
PPG IndustriesPPG
$128M+14.3%
L3Harris Technologies logo
L3Harris TechnologiesLHX
$189M+14.5%
Ametek logo
AmetekAME
$30.5M+124%
Tradeweb Markets Inc. logo
Tradeweb Markets Inc.TW
$5.87M+23.7%
Rockwell Automation logo
Rockwell AutomationROK
$13M-7.1%

Other financials

Income statement

See full
Operating income-$2.0M+61.2%
Net income-$2.5M+49.6%
EPS (diluted)-$0.05+54.5%

Balance sheet

See full
Cash & equivalents$3.1M+1,132%
Total equity$2.5M-41.5%
Total assets$3.5M

Cash flow

See full
Operating cash flow-$2.1M-191%

Valuation

See full
Market cap$115.64M

Returns & leverage

See full
Return on equity-1,209.8%
Current ratio3.5×

Where this comes from

Reported directly by Polaryx Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:DeferredTaxAssetsTaxCreditCarryforwards.

The official record: Polaryx Therapeutics, Inc. ’s 10-K, filed March 24, 2026, on SEC EDGAR. View the filing →

Ask your AI about Polaryx Therapeutics, Inc. 's deferred tax assets - tax credit carryforwards.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Polaryx Therapeutics, Inc. 's deferred tax assets - tax credit carryforwards?
Polaryx Therapeutics, Inc. (PLYX) reported deferred tax assets - tax credit carryforwards of $50K in Q4 2025.